Ashley Tapp

Ash has worked within the healthcare industry both in-house and in agency roles in the US, UK, and Europe for over 20 years and led corporate communications programmes for listed and private healthcare companies.

Prior to joining Consilium, he was an Associate Partner in Instinctif Partners’ life sciences and healthcare team. Before that, he worked in the communications team at Bristol-Myers Squibb UK & Ireland during the global launch of Opdivo® (nivolumab). Ash spent seven years as the Communications Manager at BTG plc, a highly successful international specialist healthcare company, bought by Boston Scientific in 2019 for $4.2bn. He has a passion for science and a strong network of business contacts.

Ash was awarded a BSc (Hons) in Biology degree from Imperial College, London, which included a year at the Université de Paris-Sud (XI) – Institut de Genetique et Microbiologie.

What is one thing people do not know by looking at you?

I’m a triplet with two beautiful sisters. Unfortunately, one of my sisters, Penelope, died from a brain tumour at 33. That makes me even more passionate about my work and communicating new innovations, which might make a difference in the lives of patients.

What is your proudest professional achievement?

Supporting the communication of two separate acquisitions at BTG plc which were announced on the same day, only a few days before BTG issued its financial results and in the middle of the Annual Report development. It was one of those ‘high five’ moments!

What motivates you at work?

Apart from delivering great client work, I find it highly rewarding to mentor the junior members of the team and see them achieve their ambitions.